Specht K - Search Results

1

Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.

Bange J, Prechtl D, Cheburkin Y, Specht K, Harbeck N, Schmitt M, Knyazeva T, Müller S, Gärtner S, Sures I, Wang H, Imyanitov E, Häring HU, Knayzev P, Iacobelli S, Höfler H, Ullrich A. Bange J, et al. Among authors: specht k. Cancer Res. 2002 Feb 1;62(3):840-7. Cancer Res. 2002. PMID: 11830541

2

Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue.

Specht K, Richter T, Müller U, Walch A, Werner M, Höfler H. Specht K, et al. Am J Pathol. 2001 Feb;158(2):419-29. doi: 10.1016/S0002-9440(10)63985-5. Am J Pathol. 2001. PMID: 11159180 Free PMC article.

3

Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.

Specht K, Kremer M, Müller U, Dirnhofer S, Rosemann M, Höfler H, Quintanilla-Martinez L, Fend F. Specht K, et al. Clin Cancer Res. 2002 Sep;8(9):2902-11. Clin Cancer Res. 2002. PMID: 12231535

4

Molecular analysis of gene expression in tumor pathology.

Höfler H, Specht K, Becker KF. Höfler H, et al. Among authors: specht k. Adv Exp Med Biol. 2003;532:19-26. doi: 10.1007/978-1-4615-0081-0_3. Adv Exp Med Biol. 2003. PMID: 12908546 Review.

5

Coamplification and coexpression of GRB7 and ERBB2 is found in high grade intraepithelial neoplasia and in invasive Barrett's carcinoma.

Walch A, Specht K, Braselmann H, Stein H, Siewert JR, Hopt U, Höfler H, Werner M. Walch A, et al. Among authors: specht k. Int J Cancer. 2004 Dec 10;112(5):747-53. doi: 10.1002/ijc.20411. Int J Cancer. 2004. PMID: 15386389

6

Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3.

Fuchs M, Hermannstädter C, Specht K, Knyazev P, Ullrich A, Rosivatz E, Busch R, Hutzler P, Höfler H, Luber B. Fuchs M, et al. Among authors: specht k. J Cell Physiol. 2005 Mar;202(3):805-13. doi: 10.1002/jcp.20192. J Cell Physiol. 2005. PMID: 15389640

7

Strategies to overcome resistance to targeted protein kinase inhibitors.

Daub H, Specht K, Ullrich A. Daub H, et al. Among authors: specht k. Nat Rev Drug Discov. 2004 Dec;3(12):1001-10. doi: 10.1038/nrd1579. Nat Rev Drug Discov. 2004. PMID: 15573099 Review.

8

Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients.

Napieralski R, Ott K, Kremer M, Specht K, Vogelsang H, Becker K, Müller M, Lordick F, Fink U, Rüdiger Siewert J, Höfler H, Keller G. Napieralski R, et al. Among authors: specht k. Clin Cancer Res. 2005 Apr 15;11(8):3025-31. doi: 10.1158/1078-0432.CCR-04-1605. Clin Cancer Res. 2005. PMID: 15837757 Clinical Trial.

9

Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma.

Langer R, Specht K, Becker K, Ewald P, Bekesch M, Sarbia M, Busch R, Feith M, Stein HJ, Siewert JR, Höfler H. Langer R, et al. Among authors: specht k. Clin Cancer Res. 2005 Oct 15;11(20):7462-9. doi: 10.1158/1078-0432.CCR-05-0042. Clin Cancer Res. 2005. PMID: 16243820

10

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

Foekens JA, Atkins D, Zhang Y, Sweep FC, Harbeck N, Paradiso A, Cufer T, Sieuwerts AM, Talantov D, Span PN, Tjan-Heijnen VC, Zito AF, Specht K, Hoefler H, Golouh R, Schittulli F, Schmitt M, Beex LV, Klijn JG, Wang Y. Foekens JA, et al. Among authors: specht k. J Clin Oncol. 2006 Apr 10;24(11):1665-71. doi: 10.1200/JCO.2005.03.9115. Epub 2006 Feb 27. J Clin Oncol. 2006. PMID: 16505412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters